2026 BioJapan World Business Forum, Yokohama, Japan

The 2026 BioJapan World Business Forum in Yokohama, Japan, is one of the most influential annual events in the biotechnology sector in Asia and globally. Since its inception, this exhibition has been dedicated to promoting innovation and cooperation in the bio-industry, evolving into a crucial platform connecting global biotech companies, research institutions, academia, and investors. BioJapan is grandly held annually at PACIFICO Yokohama, attracting industry elites from around the world due to its highly specialized and international characteristics. The exhibition is extensive, typically encompassing hundreds of exhibitors and tens of thousands of professional visitors, including biopharmaceutical giants, emerging biotech companies, CRO/CDMO service providers, diagnostic technology developers, medical device manufacturers, agricultural biotechnology companies, and innovators in biofuels and biomaterials. BioJapan is not just a platform for product and technology display; it is a comprehensive ecosystem that fosters business cooperation, technology transfer, project financing, and knowledge exchange. During the exhibition, a series of high-level seminars, keynote speeches, roundtables, and one-on-one business matching events are held, delving into cutting-edge biotechnology trends, industry policies, market opportunities, and challenges. Its influence is reflected in its ability to effectively facilitate cross-border cooperation projects, accelerate new drug R&D processes, promote the commercialization of innovative technologies, and inject new vitality into the healthy development of the global bio-industry. For biotech companies looking to enter the Asian market or seek international cooperation, BioJapan is undoubtedly an unmissable strategic platform.

The exhibit range of the 2026 BioJapan World Business Forum in Yokohama, Japan, is extremely broad, covering all aspects of the biotechnology value chain, aiming to comprehensively showcase the latest technologies, products, and services in the bio-industry. Key exhibit categories include: 1. Biopharmaceuticals and Biologics: Covering gene-engineered drugs, cell therapy products, antibody drugs, vaccines, diagnostic reagents, blood products, biosimilars, biobetters, as well as R&D, production, and quality control technologies for biologics. 2. Genomics and Proteomics: Including gene sequencing technologies and equipment, gene editing tools (such as CRISPR), high-throughput screening, bioinformatics analysis software, protein expression and purification systems, protein structure analysis, antibody engineering, etc. 3. Cell Biology and Regenerative Medicine: Involving stem cell research and applications, cell culture technologies and media, cell therapy products, tissue engineering, biomaterials, 3D bioprinting technology, and related laboratory equipment and consumables. 4. Bioprocess and Biomanufacturing: Showcasing bioreactors, fermenters, separation and purification equipment, aseptic filling systems, biopharmaceutical production lines, process control and automation systems, single-use technologies, and GMP-compliant production solutions. 5. Diagnostic Technologies and Medical Devices: Including in vitro diagnostic (IVD) products, molecular diagnostics, immunoassays, POCT devices, medical imaging technologies, biosensors, wearable medical devices, and related data management and analysis systems. 6. Agricultural Biotechnology and Food Science: Covering genetically modified crops, biopesticides, biofertilizers, animal vaccines, feed additives, functional foods, nutritional supplements, food safety testing technologies, and applications of microbial fermentation in food production. 7. Bioenergy and Biomaterials: Showcasing biofuels (such as bioethanol, biodiesel), bioplastics, bio-based chemicals, biodegradable materials, and technologies for converting biomass resources into energy and materials. 8. CRO/CDMO Services: Providing comprehensive outsourcing services such as preclinical research, clinical trials, contract research and manufacturing, regulatory consulting, intellectual property services, biobank management, data management, and statistical analysis. 9. Laboratory Equipment and Consumables: Including spectrophotometers, chromatographs, mass spectrometers, PCR machines, centrifuges, microscopes, incubators, ultra-low temperature freezers, pipettes, reagent kits, laboratory automation systems, safety protective equipment, etc. 10. Biotech Investment and Intellectual Property: Offering venture capital, private equity, government funds, technology licensing, patent application and management, market analysis and consulting services, promoting investment and cooperation in the biotechnology sector. These exhibit categories collectively form the diversified display content of BioJapan, providing attendees with a broad platform to comprehensively understand cutting-edge developments in the bio-industry and seek cooperation opportunities.

No fee information available. Please contact us for a quote.